Not all clients with CLL need therapy. Inspite of all the latest improvements, the iwCLL however recommends watchful observation for people with asymptomatic disease.86 This recommendation relies on at the least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).MPO777